← All trials
NCT06494007
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2023
- Primary completion
- Jun 1, 2024
- Completion date
- Jul 1, 2024
- First posted
- Jul 10, 2024
- Last posted
- Jul 11, 2024
- Enrollment
- 217
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Haseki Training and Research HospitalLead sponsor
- Haseki Training and Research HospitalOfficial
- Haseki Training and Research HospitalSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.